Roger D Cox

Title: Roger D Cox: Innovator in Genetic Research

Introduction

Roger D Cox is a notable inventor based in Oxon, GB. He has made significant contributions to the field of genetic research, particularly in relation to type 1 diabetes and other autoimmune diseases. With a total of 3 patents, his work has implications for various medical treatments and diagnostics.

Latest Patents

Cox's latest patents include a method of screening for modulators of LRP5 activity. This invention introduces a novel receptor known as 'LDL-receptor-related protein-5' (LRP-5), which is associated with type 1 diabetes. The patent outlines the provision of nucleic acid, including coding sequences, oligonucleotide primers and probes, polypeptides, and pharmaceutical compositions. It also details methods of diagnosis or prognosis related to the gene, which may be implicated in several diseases, including autoimmune diseases, viral infections, and diabetes. Another significant patent involves the LDL-receptor, specifically a novel receptor termed 'LDL-receptor related protein-3' (LRP-3), which shares similar associations and applications as the LRP-5 receptor.

Career Highlights

Throughout his career, Roger D Cox has worked with esteemed organizations, including The Wellcome Trust Limited, where he served as a trustee. His research has been pivotal in advancing our understanding of genetic factors in diseases, particularly those affecting the immune system.

Collaborations

Cox has collaborated with notable individuals in the field, including John A Todd and John W Hess. These partnerships have contributed to the depth and breadth of his research endeavors.

Conclusion

Roger D Cox's innovative work in genetic research has led to significant advancements in understanding and treating diseases like type 1 diabetes. His contributions continue to influence the medical field and offer hope for future therapies.